powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1649581752
James Dean
D.O.
Pulmonary Disease
Mobile,
AL
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
PRESCRIBING · PART D · 2024
Total Rx claims
4,756
Beneficiaries
—
Total drug cost
$2.0M
Distinct drugs
29
Brand share
77.2%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter
1,336 claims
Albuterol Sulfate
1,260 claims
Levocetirizine Dihydrochloride
289 claims
Fluticasone/Vilanterol
231 claims
Prednisone
209 claims
QUALITY · MIPS · 2024
Final MIPS score
99.4
Quality
12.4
Cost
74.8
Improvement activities
40.0
Promoting interop.
96.0
Payment adjustment
1.03%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,342
Unique beneficiaries
—
Total services
4,136
Distinct HCPCS
29
Medicare payment
$186K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 167 Pulmonary Disease providers in AL — top quintile (cohort median 943).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$931
Payment records
51
By payment type
Food and Beverage
$931
Top paying entities
Food and Beverage
$931
